Webinars and Sponsored Roundtables — Register Now

Wednesday, September 23, 2026. 12 PM-1 PM ET
Roundtable presenters Dr. David Sacks MB, ChB, FRCPath, Chairman, Steering Committee National Glycohemoglobin Standardization Program (NGSP), and Priya Sivaraman, PhD, Senior Technical Product Manager, Tosoh Bioscience.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Thursday, September 24, 2026 11 AM-12 PM CT
This session explores the evolving role of RAS in precision oncology, from the biology of RAS mutations to the expanding landscape of targeted therapies. Through expert presentations, real-world case discussions, and interactive audience polling, participants will examine best practices for RAS biomarker testing across solid tumors, including lung, colorectal, and pancreatic cancers. The session will highlight practical considerations for tissue and liquid biopsy, strategies to address testing gaps, and the importance of multidisciplinary collaboration to ensure timely identification of patients who may benefit from RAS-targeted therapies.

Webinar presenters David Braxton, MD, Chief of Molecular Pathology Services, Hoag Family Cancer Institute & Hoag Memorial Hospital Presbyterian, and Carlos Becerra, MD, Research Director for Medical Oncology, Margaret Given Larkin Endowed Chair for Developmental Cancer Therapeutics, Hoag Memorial Hospital Presbyterian.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Wednesday, September 30, 2026. 1 PM-1:30 PM ET
Roundtable presenters John Longshore, PhD, Head of Scientific Affairs, Global Oncology Diagnostics, AstraZeneca, and Flora Berisha, MS, Executive Director, Global Head of Diagnostic Partnering and Development, Johnson & Johnson Innovative Medicine, and Mark D. Ewalt, MD, Associate Medical Director for Laboratory Operations, Diagnostic Molecular Pathology, Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, and Isabel Preeshagul, DO, MBS, Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer Center.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Tuesday, October 20, 2026 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.

Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology,
Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Subspecialties

Interactive Product Guides

Product Spotlight

Siemens Healthineers

Atellica Solution

Company

Siemens Healthineers

Name of instrument

Atellica Solution

Contact

Tony Gaglio   

Email

anthony.gaglio@siemens-healthineers.com

City, State

Tarrytown, NY 

Phone

800-888-7436   

Website

http://www.siemens-healthineers.com/en-us 

Type of instrument

combination chemistry/immunoassay

List price/First year sold in U.S.

—/2017

Targeted hospital bed size/Targeted test volume

—/annual: > 1 million

Company manufactures instrument

yes (also sold by McKesson, Henry Schein, Medline, Cardinal) 

Other models in this family of analyzers

Atellica CH 930, IM 1300, IM 1600

No. of units in clinical use in U.S./Outside U.S. (countries)

Dimensions (H × W × D)/Instrument footprint

chem: 53.7 × 58.6 × 45.5 in.; immuno: 59.1 × 56.9 × 45.0 in./64.6 sq. ft.

Weight empty/Weight fully loaded

chem: 1,036 lbs.; immuno: 1,265 lbs./—

No. of different measured assays onboard simultaneously

chem: up to 70 (up to 70 can be run and calibrated at one time); immuno: up to 42 (up to 42 can be run and calibrated at one time)

No. of user-definable (open chemistry) channels

25 (25 can be active simultaneously)

Test throughput per hour/Assay run time

2,240 (up to 1,800 chem, up to 440 immuno tests in throughput)/18 sec.–54 min. (assay dependent)

No. of direct ion-selective electrode channels

3

Detection methods

photometry, potentiometry, turbidimetric, EMIT

Stat time until completion/specimen throughput for Ion-selective electrode

18–27 sec./— 

Stat time until completion/specimen throughput for Ion-selective electrode basic metabolic panel

10 min./—

Stat time until completion/specimen throughput for Ion-selective electrode complete metabolic panel

10 min./—

Typical time delay from ordering stat test until aspiration of sample

6–60 sec. maximum

Fully automated microplate immunoassay system

no

Methodologies supported

chemiluminescence, enzyme immunoassay, acridinium ester chemiluminescence

Separation methodologies

magnetic particle

Stat time until completion of a ß-hCG test

10 min.

Stat time until completion of a cTn test

10 min.

• Typical time delay from test order to aspiration of sample

6–60 sec. 

Reagents refrigerated onboard/Reagents ready to use

yes (4°–8°C)/yes

Reagent lot tracking/Reagent inventory

yes/yes

Reagent form/Reagents barcoded

liquid chemistry (open reagent system)/yes

Separate reagent pack for each specimen/for each test run

no/no

Walkaway capability/Walkaway duration

yes/300 min. or 9,000 tests (chem), 450 min. or 1,200 tests (immuno)

Design of sample-handling system

multiple rack drawer, single sample transport

Uses washable cuvettes/Uses disposable cuvettes

yes/yes (can store up to 221 cuvettes for chem, up to 1,200 for immuno)

Min.–max. sample volume that can be aspirated at one time 

2–50 µL (chem), 10–200 µL (immuno)

Min. reaction volume/Min. specimen volume/Min. dead volume

assay dependent/assay dependent/container dependent

Dedicated pediatric sample cup

no

Primary tube sampling

yes

Accommodates most standard tube sizes/Accepts nonstandard tube sizes

yes/yes

Pierces caps on primary tubes

no

Protects against probe collision

no

Detects clots/liquid level/short sample

yes/yes/yes

Detection or quantitation for hemolysis, icterus, lipemia, clots

detection and quantitation for hemolysis, icterus, lipemia; detection for clots

Dilutes patient samples onboard/Susceptibility to carryover

yes (can be programmed to perform dilutions prior to analysis)/­—

Automatic rerun capability

yes

Sample volume can be diluted to rerun out-of-linear-range high results

yes

Sample volume can be concentrated to rerun out-of-linear-range low results

yes

Autocalibration/Multipoint calibration supported

yes (calibrants can be stored onboard)/yes (recommended avg. frequency: 28–183 days [chem], 14–91 days [immuno])

Typical calibration frequency for ISE/therapeutic drugs/drugs of abuse/general chemistries/immunoassays

4 hrs./28–63 days/40–180 days/up to 180 days/up to 91 days

Automatic programmable start/Automatic programmable shutdown

yes/yes

Onboard real-time QC/Onboard software capability to review QC

yes/yes

Supports multiple QC lot numbers per analyte

yes

Waste management

automated collection onboard instrument or direct to drain

Sample barcode-reading capability/Autodiscrimination

yes (Interleaved 2 of 5, Codabar, Code 39, Code 128)/yes

Lab can control analyzer from remote computer

yes

Instrument can diagnose its own malfunctions

yes (operator intervention required to order parts)

System malfunctions can be diagnosed via remote monitoring

yes

UPS backup power supply

yes

Data-management capability/LIS or EHR systems interfaced

onboard, optional add-on (Siemens Atellica Data Manager)/Meditech, Clinisys, Oracle Health, Labdaq, Epic Beaker, more

LIS interface provided/Bidirectional interface capability

yes (incl. in price)/yes (broadcast download and host query)

Modem servicing provided/Service engineer on-site response time

yes/5 hrs. avg.

Mean time between failures

— (displays error codes for troubleshooting)

Average scheduled maintenance time by lab personnel

daily: < 5 min.; weekly: 15 min.; monthly: 15 min.

Maintenance records kept onboard for user/vendor

yes/yes (both include audit trail of who replaced parts)

Maintenance training demonstration module onboard

yes

Training included with purchase/Avg. time for basic user training

yes (3 training slots)/6.5 days (at customer or vendor site)

Advanced operator training/Extra charge for follow-up or advanced training

yes (at vendor site)/yes

Warranty provided/Cost of annual service contract (24 h/7 d)

yes (1 year)/—

Distinguishing features (supplied by company)

individual sample carriers provide intelligent sample routing; integrated automation for decapping, sealing; dedicated high-capacity refrigerated, covered calibration and QC materials onboard with automatic deployment; microvolume sample technology for CC; IA controlled temperature requires no recalibration if laboratory ambient temp. changes

More products
in this guide

Alinity ci-series
ASI Evolution RPR Syphilis Analyzer
DxI 9000 Access Immunoassay Analyzer
Pictus 700 (P700)
Agility Automated ELISA System
AIX1000 Agglutination Instrument
Yumizen C1200
Yumizen C560
VITROS 3600 Immunodiagnostic System
VITROS XT 7600 Integrated System
cobas pro integrated solutions
dIFine P30 Processor
IMMULITE 2000 XPi Immunoassay System
Phadia 250 Laboratory System
B⋅R⋅A⋅H⋅M⋅S KRYPTOR GOLD
QUANTA-Lyser 3000